Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for OPICAPONE
- eArly levoDopa With Opicapone in Parkinson's paTients wIth motOr fluctuatioNs.
- OpicApone Sleep dISorder
- OpiCapone Effect on Motor Fluctuations and pAiN
- Early ParkinSon wIth L-DOPA/DDCI and OpicapoNe (EPSILON Study)
- A Study to Evaluate the add-on Efficacy and Safety of Opicapone 50 mg or an Extra Dose of L-DOPA 100 mg for the Treatment of Wearing-off in Patients With PD
- Bioavailability and Bioequivalence Between Two Active Pharmaceutical Ingredient (API) Sources of Opicapone (OPC)
- Relative Bioavailability and Bioequivalence of Opicapone
- A Study of the Pharmacokinetics, Pharmacodynamics, and Safety of Opicapone in Subjects With Parkinson's Disease Taking Levodopa.
- Bioavailability and Bioequivalence Study of Two Different Sources of Opicapone
- Efficacy and Safety of Opicapone in Clinical Practice
- Dosage Form Proportionality of Opicapone To-Be-Marketed Formulation
- Single-dose Pharmacokinetics and Relative Bioavailability of Two Different Formulations of Opicapone
- Relative Bioavailability and Bioequivalence Of Different Formulations of Opicapone in Healthy Volunteers
- Effect of Opicapone at Steady State on Warfarin Pharmacokinetics
- Effect of Paracetamol on Opicapone Pharmacokinetics in Healthy Volunteers
- The Effect of BIA 9-1067 at Steady-state on the Levodopa Pharmacokinetics
- Pharmacokinetics of BIA 9-1067 in Subjects With Hepatic Impairment
- Continuation Treatment Protocol for Patient Who Participated in the BIA 9-1067-302 Clinical Trial
- Absorption, Distribution, Metabolism and Excretion of [14C]-Labeled BIA 9-1067 and Metabolites
- Efficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients.
Clinical trials list
click for details